Zhu Yanxia, Liao Yuqi, Zhang Yuanyuan, Shekh Mehdihasan I, Zhang Jianhao, You Ziyang, Du Bing, Lian Cuihong, He Qianjun
Shenzhen Key Laboratory for Anti-ageing and Regenerative Medicine, Department of Medical Cell Biology & Genetics, Health Science Center Shenzhen University Shenzhen China.
Guangdong Provincial Key Laboratory of Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Health Science Center Shenzhen University Shenzhen China.
Bioeng Transl Med. 2021 Aug 12;7(1):e10244. doi: 10.1002/btm2.10244. eCollection 2022 Jan.
The integration of biomaterials with cells for high overall performances is vitally important in tissue engineering, as scaffold-free cell sheet lacks enough mechanical performance and cell viability while cell-free scaffold possesses limited biological functions. In this study, we propose a new strategy to strengthen cell sheets and enhance cell activity for accelerating wound healing based on a novel sandwich structure of cell sheet-plasmid@membrane-cell sheet (CpMC). Specifically, the CpMC contains two adipose-derived stem cell (ADSC) sheets on outer surfaces and an electrospun gelatin/chitosan nanofibrous membrane (NFM) encapsulating vascular endothelial growth factor (VEGF) plasmids in between. The physicochemical properties of NFM including swelling, stiffness, strength, elasticity, and biodegradation can be tailored by simply adjusting the ratio between gelatin and chitosan to be 7:3 which is optimal for most effectively supporting ADSCs adhesion and proliferation. The swelling/biodegradation of NFM mediates the sustained release of encapsulated VEGF plasmids into adjacent ADSCs, and NFM assists VEGF plasmids to promote the differentiation of ADSCs into endothelial, epidermal, and fibroblast cells, in support of the neoangiogenesis and regeneration of cutaneous tissues within 2 weeks. The proposed membrane-supporting cell sheet strategy provides a new route to tissue engineering, and the developed CpMC demonstrates a high potential for clinical translation.
在组织工程中,将生物材料与细胞整合以实现高整体性能至关重要,因为无支架细胞片缺乏足够的机械性能和细胞活力,而无细胞支架的生物学功能有限。在本研究中,我们基于一种新型的细胞片 - 质粒@膜 - 细胞片(CpMC)三明治结构,提出了一种强化细胞片并增强细胞活性以加速伤口愈合的新策略。具体而言,CpMC在外表面包含两个脂肪来源干细胞(ADSC)片,中间是包裹血管内皮生长因子(VEGF)质粒的静电纺丝明胶/壳聚糖纳米纤维膜(NFM)。通过简单地将明胶与壳聚糖的比例调整为7:3(这对于最有效地支持ADSCs的粘附和增殖是最佳的),可以调整NFM的物理化学性质,包括膨胀性、硬度、强度、弹性和生物降解性。NFM的膨胀/生物降解介导了封装的VEGF质粒向相邻ADSCs的持续释放,并且NFM协助VEGF质粒促进ADSCs向内皮细胞、表皮细胞和成纤维细胞的分化,以支持皮肤组织在2周内的新生血管生成和再生。所提出的膜支持细胞片策略为组织工程提供了一条新途径,并且所开发的CpMC具有很高的临床转化潜力。